AlTi Global’s Elevance Health ELV Stock Holding History

AlTi Global’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-460	Closed	-$249K	–	392
2024 Q2	$249K	Sell	460 -96	-17%	-$50.7K	0.01%	341
2024 Q1	$288K	Buy	+556	New	+$277K	0.01%	320

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

AlTi Global's ELV Position: Q3 2024 in Review

AlTi Global sold out of Elevance Health (ELV) in Q3 2024, closing a stake of 460 shares — an estimated $249K sold.

AlTi Global first reported a position in ELV in Q1 2024 and held it in 2 quarters. The position peaked at $288K in Q1 2024. 1,693 funds tracked by Wall St. Rank hold ELV as of Q3 2024.

AlTi Global reported no remaining Elevance Health position as of Q3 2024 after selling out during the quarter.
AlTi Global sold 460 Elevance Health shares in Q3 2024, an estimated $249K.
AlTi Global first reported a position in Elevance Health in Q1 2024 and held it in 2 quarters.
AlTi Global's Elevance Health position peaked at $288K in Q1 2024.
1,693 funds tracked by Wall St. Rank held Elevance Health as of Q3 2024.

Based on AlTi Global's 13F filing for Q3 2024, filed 14 Nov 2024.